For instance in breast cancer, ESP subtypes were significantly correlated with Estrogen Receptor and HER2 expression status, while in uterine cancer, subtypes were significantly correlated with the histological subtype, serous vs. endometrioid. This evidence concerns the gene ERBB2 and breast carcinoma.